Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FDSTU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,113
Award facts
- Contract value 100% obligated
- $54,113.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54,113.48 delivery order to AmerisourceBergen Drug Corp for Cosentyx Unoready 300 mg pen 2 ml, with an ultimate completion date of October 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was issued on October 27, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Cosentyx (secukinumab) is a biologic immunosuppressant used primarily for autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its established capability to meet defense medical supply requirements through open competition and its position as a key provider within the DLA's pharmaceutical supply chain supporting military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FDSTU?
SPE2DB26FDSTU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FDSTU worth?
The government has obligated $54,113 on SPE2DB26FDSTU.
Is contract SPE2DB26FDSTU an order under another contract?
Yes. SPE2DB26FDSTU is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB26FDSTU competed?
The extent of competition for SPE2DB26FDSTU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award